Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Gancotamab (Synonyms: MM-302, MM302)

Catalog No. T77017 Copy Product Info
🥰Excellent
Gancotamab (MM-302) is a HER2-targeting polyethylene glycolated liposome that encapsulates adriamycin to facilitate delivery to HER2-overexpressing tumor cells while limiting exposure to non-target tissues, including the heart.Gancotamab has antitumor activity and may be used to study advanced HER2-positive breast cancer.

Gancotamab

Copy Product Info
🥰Excellent
Catalog No. T77017
Synonyms MM-302, MM302

Gancotamab (MM-302) is a HER2-targeting polyethylene glycolated liposome that encapsulates adriamycin to facilitate delivery to HER2-overexpressing tumor cells while limiting exposure to non-target tissues, including the heart.Gancotamab has antitumor activity and may be used to study advanced HER2-positive breast cancer.

Gancotamab
Cas No. 1509928-00-0
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$163In StockIn Stock
5 mg$428In StockIn Stock
10 mg$679-In Stock
25 mg$987-In Stock
50 mg$1,380-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:96.7% (SDS-PAGE); 98.4% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Gancotamab (MM-302) is a HER2-targeting polyethylene glycolated liposome that encapsulates adriamycin to facilitate delivery to HER2-overexpressing tumor cells while limiting exposure to non-target tissues, including the heart.Gancotamab has antitumor activity and may be used to study advanced HER2-positive breast cancer.
In vitro
Gancotamab is a liposomal drug targeting HER2 that carries approximately 20,000 Doxorubicin molecules in its core and 45 single-chain anti-HER2 antibodies attached to its surface. [1]
Gancotamab (0.5 μM; 72 hr treatment) promotes increased mortality in BT474-M3 and NCI-N87 cells. [1]
Gancotamab (1 μM; 2-24 hrs) induces activation of p-p53 levels in BT474-M3 and NCI-N87 cells, but has no significant effect on p-Akt signaling. [1]
In vivo
Gancotamab (3 mg/kg; i.v. every 7 days; 3 doses) has a significant inhibitory effect on tumor growth and upregulates the expression of p-p53, a DNA damage marker. [1]
SynonymsMM-302, MM302
Reactivity
Human
Application
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Gene ID
Uniprot ID
TargetERBB2/HER2/CD340
Chemical Properties
Molecular Weight25.79 kDa
Cas No.1509928-00-0
Antibody Information
IsotypeIgG1
Storage & Solubility Information
Storage-20°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Citations

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Gancotamab | purchase Gancotamab | Gancotamab cost | order Gancotamab | Gancotamab in vivo | Gancotamab in vitro | Gancotamab molecular weight